These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 34885021)

  • 1. Directing the Future Breakthroughs in Immunotherapy: The Importance of a Holistic Approach to the Tumour Microenvironment.
    Newnes HV; Armitage JD; Audsley KM; Bosco A; Waithman J
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine-Tuning the Tumour Microenvironment: Current Perspectives on the Mechanisms of Tumour Immunosuppression.
    Armitage JD; Newnes HV; McDonnell A; Bosco A; Waithman J
    Cells; 2021 Jan; 10(1):. PubMed ID: 33401460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Tumour-Associated Fibroblasts in Cancers.
    Shah K; Mallik SB; Gupta P; Iyer A
    Front Oncol; 2022; 12():908156. PubMed ID: 35814453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of Single-Cell Omics to Dissect Tumor Microenvironment.
    Guo T; Li W; Cai X
    Front Genet; 2020; 11():548719. PubMed ID: 33329692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineating spatial cell-cell interactions in the solid tumour microenvironment through the lens of highly multiplexed imaging.
    Cohn DE; Forder A; Marshall EA; Vucic EA; Stewart GL; Noureddine K; Lockwood WW; MacAulay CE; Guillaud M; Lam WL
    Front Immunol; 2023; 14():1275890. PubMed ID: 37936700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?
    O'Malley G; Heijltjes M; Houston AM; Rani S; Ritter T; Egan LJ; Ryan AE
    Oncotarget; 2016 Sep; 7(37):60752-60774. PubMed ID: 27542276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organoids as an Enabler of Precision Immuno-Oncology.
    Zhao J; Fong A; Seow SV; Toh HC
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal Molecular Imaging of the Tumour Microenvironment.
    Foray C; Barca C; Backhaus P; Schelhaas S; Winkeler A; Viel T; Schäfers M; Grauer O; Jacobs AH; Zinnhardt B
    Adv Exp Med Biol; 2020; 1225():71-87. PubMed ID: 32030648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours.
    Cheng YQ; Wang SB; Liu JH; Jin L; Liu Y; Li CY; Su YR; Liu YR; Sang X; Wan Q; Liu C; Yang L; Wang ZC
    Cell Prolif; 2020 Aug; 53(8):e12865. PubMed ID: 32588948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Roles of CD38 and CD157 in the Solid Tumor Microenvironment and Cancer Immunotherapy.
    Wo YJ; Gan ASP; Lim X; Tay ISY; Lim S; Lim JCT; Yeong JPS
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma.
    Fan JQ; Wang MF; Chen HL; Shang D; Das JK; Song J
    Mol Cancer; 2020 Feb; 19(1):32. PubMed ID: 32061257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Underlying mechanisms and drug intervention strategies for the tumour microenvironment.
    Li H; Zhou L; Zhou J; Li Q; Ji Q
    J Exp Clin Cancer Res; 2021 Mar; 40(1):97. PubMed ID: 33722297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric Antigen Receptors for the Tumour Microenvironment.
    Habib R; Nagrial A; Micklethwaite K; Gowrishankar K
    Adv Exp Med Biol; 2020; 1263():117-143. PubMed ID: 32588326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Potential of Lymphoid Infiltrates in Breast Cancer.
    Chen XY; Tan PH
    Curr Med Chem; 2021; 28(25):5152-5178. PubMed ID: 33938409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity.
    Donlon NE; Power R; Hayes C; Reynolds JV; Lysaght J
    Cancer Lett; 2021 Apr; 502():84-96. PubMed ID: 33450360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of single-cell multi-omics in liver cancer.
    Peeters F; Cappuyns S; Piqué-Gili M; Phillips G; Verslype C; Lambrechts D; Dekervel J
    JHEP Rep; 2024 Jul; 6(7):101094. PubMed ID: 39022385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unravelling Tumour Microenvironment in Melanoma at Single-Cell Level and Challenges to Checkpoint Immunotherapy.
    Bai X; Quek C
    Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy.
    Smith PL; Piadel K; Dalgleish AG
    Vaccines (Basel); 2021 Nov; 9(12):. PubMed ID: 34960140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved Anti-Tumour Adaptive Immunity Can Overcome the Melanoma Immunosuppressive Tumour Microenvironment.
    Dang N; Waer M; Sprangers B; Lin Y
    Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31683642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Immunotherapies: From Efficacy to Resistance Mechanisms - Not Only Checkpoint Matters.
    Wang S; Xie K; Liu T
    Front Immunol; 2021; 12():690112. PubMed ID: 34367148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.